ID   DECR_HUMAN              Reviewed;         335 AA.
AC   Q16698; B7Z6B8; Q2M304; Q93085;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=2,4-dienoyl-CoA reductase, mitochondrial;
DE            EC=1.3.1.34 {ECO:0000269|PubMed:15531764};
DE   AltName: Full=2,4-dienoyl-CoA reductase [NADPH];
DE            Short=4-enoyl-CoA reductase [NADPH];
DE   AltName: Full=Short chain dehydrogenase/reductase family 18C member 1;
DE   Flags: Precursor;
GN   Name=DECR1; Synonyms=DECR, SDR18C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=7818482; DOI=10.1042/bj3040787;
RA   Koivuranta K.T., Hakkola E.H., Hiltunen J.K.;
RT   "Isolation and characterization of cDNA for human 120 kDa
RT   mitochondrial 2,4-dienoyl-coenzyme A reductase.";
RL   Biochem. J. 304:787-792(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Ding J.H., Yang B.Z., Roe C.R.;
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9403065; DOI=10.1006/geno.1997.5004;
RA   Helander H.M., Koivuranta K.T., Horelli-Kuitunen N., Palvimo J.J.,
RA   Palotie A., Hiltunen J.K.;
RT   "Molecular cloning and characterization of the human mitochondrial
RT   2,4-dienoyl-CoA reductase gene (DECR).";
RL   Genomics 46:112-119(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pericardium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-230, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   INVOLVEMENT IN DECRD.
RX   PubMed=24847004; DOI=10.1093/hmg/ddu218;
RA   Houten S.M., Denis S., Te Brinke H., Jongejan A., van Kampen A.H.,
RA   Bradley E.J., Baas F., Hennekam R.C., Millington D.S., Young S.P.,
RA   Frazier D.M., Gucsavas-Calikoglu M., Wanders R.J.;
RT   "Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes
RT   dienoyl-CoA reductase deficiency with hyperlysinemia.";
RL   Hum. Mol. Genet. 23:5009-5016(2014).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-69, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 35-335 IN COMPLEX WITH NADP
RP   AND SUBSTRATE, CATALYTIC ACTIVITY, SUBUNIT, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF ASN-148; TYR-199; SER-210 AND LYS-214.
RX   PubMed=15531764; DOI=10.1074/jbc.M411069200;
RA   Alphey M.S., Yu W., Byres E., Li D., Hunter W.N.;
RT   "Structure and reactivity of human mitochondrial 2,4-dienoyl-CoA
RT   reductase: enzyme-ligand interactions in a distinctive short-chain
RT   reductase active site.";
RL   J. Biol. Chem. 280:3068-3077(2005).
CC   -!- FUNCTION: Auxiliary enzyme of beta-oxidation. It participates in
CC       the metabolism of unsaturated fatty enoyl-CoA esters having double
CC       bonds in both even- and odd-numbered positions. Catalyzes the
CC       NADP-dependent reduction of 2,4-dienoyl-CoA to yield trans-3-
CC       enoyl-CoA.
CC   -!- CATALYTIC ACTIVITY: Trans-2,3-didehydroacyl-CoA + NADP(+) =
CC       trans,trans-2,3,4,5-tetradehydroacyl-CoA + NADPH.
CC       {ECO:0000269|PubMed:15531764}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=7.7 uM for NADPH {ECO:0000269|PubMed:15531764};
CC         KM=14.3 uM for trans-2,trans-4-hexadienoyl-CoA
CC         {ECO:0000269|PubMed:15531764};
CC         Vmax=30.3 umol/min/mg enzyme {ECO:0000269|PubMed:15531764};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15531764}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16698-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16698-2; Sequence=VSP_056388;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Heart = liver = pancreas > kidney >> skeletal
CC       muscle = lung. {ECO:0000269|PubMed:7818482}.
CC   -!- DISEASE: 2,4-dienoyl-CoA reductase deficiency (DECRD)
CC       [MIM:616034]: A rare, autosomal recessive, inborn error of
CC       polyunsaturated fatty acids and lysine metabolism, resulting in
CC       mitochondrial dysfunction. Affected individuals have a severe
CC       encephalopathy with neurologic and metabolic abnormalities
CC       beginning in early infancy. Laboratory studies show increased
CC       C10:2 carnitine levels and hyperlysinemia.
CC       {ECO:0000269|PubMed:24847004}. Note=The protein represented in
CC       this entry is involved in disease pathogenesis. A selective
CC       decrease in mitochondrial NADP(H) levels due to NADK2 mutations
CC       causes a deficiency of NADPH-dependent mitochondrial enzymes, such
CC       as DECR1 and AASS. {ECO:0000269|PubMed:24847004}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. 2,4-dienoyl-CoA reductase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L26050; AAA67551.1; -; mRNA.
DR   EMBL; U49352; AAB09423.1; -; mRNA.
DR   EMBL; U78302; AAB88724.1; -; Genomic_DNA.
DR   EMBL; U94980; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; U94981; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; U94982; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; U94983; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; U94984; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; U94985; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; U94986; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; U94987; AAB88724.1; JOINED; Genomic_DNA.
DR   EMBL; AK300069; BAH13204.1; -; mRNA.
DR   EMBL; AC004612; AAC14671.1; -; Genomic_DNA.
DR   EMBL; AF049895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC105080; AAI05081.1; -; mRNA.
DR   EMBL; BC105082; AAI05083.1; -; mRNA.
DR   CCDS; CCDS6250.1; -. [Q16698-1]
DR   PIR; S53352; S53352.
DR   RefSeq; NP_001317504.1; NM_001330575.1. [Q16698-2]
DR   RefSeq; NP_001350.1; NM_001359.1. [Q16698-1]
DR   RefSeq; XP_016868636.1; XM_017013147.1. [Q16698-2]
DR   RefSeq; XP_016868637.1; XM_017013148.1. [Q16698-2]
DR   UniGene; Hs.492212; -.
DR   UniGene; Hs.660770; -.
DR   PDB; 1W6U; X-ray; 1.75 A; A/B/C/D=35-335.
DR   PDB; 1W73; X-ray; 2.10 A; A/B/C/D=35-335.
DR   PDB; 1W8D; X-ray; 2.20 A; A/B/C/D=35-335.
DR   PDBsum; 1W6U; -.
DR   PDBsum; 1W73; -.
DR   PDBsum; 1W8D; -.
DR   ProteinModelPortal; Q16698; -.
DR   SMR; Q16698; -.
DR   BioGrid; 108030; 34.
DR   IntAct; Q16698; 22.
DR   STRING; 9606.ENSP00000220764; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   SwissLipids; SLP:000001049; -.
DR   iPTMnet; Q16698; -.
DR   PhosphoSitePlus; Q16698; -.
DR   SwissPalm; Q16698; -.
DR   BioMuta; DECR1; -.
DR   DMDM; 3913456; -.
DR   UCD-2DPAGE; Q16698; -.
DR   EPD; Q16698; -.
DR   MaxQB; Q16698; -.
DR   PaxDb; Q16698; -.
DR   PeptideAtlas; Q16698; -.
DR   PRIDE; Q16698; -.
DR   TopDownProteomics; Q16698-1; -. [Q16698-1]
DR   TopDownProteomics; Q16698-2; -. [Q16698-2]
DR   Ensembl; ENST00000220764; ENSP00000220764; ENSG00000104325. [Q16698-1]
DR   Ensembl; ENST00000522161; ENSP00000429779; ENSG00000104325. [Q16698-2]
DR   GeneID; 1666; -.
DR   KEGG; hsa:1666; -.
DR   UCSC; uc003yek.2; human. [Q16698-1]
DR   CTD; 1666; -.
DR   DisGeNET; 1666; -.
DR   GeneCards; DECR1; -.
DR   HGNC; HGNC:2753; DECR1.
DR   HPA; HPA023160; -.
DR   HPA; HPA023162; -.
DR   HPA; HPA023238; -.
DR   MalaCards; DECR1; -.
DR   MIM; 222745; gene.
DR   MIM; 616034; phenotype.
DR   neXtProt; NX_Q16698; -.
DR   OpenTargets; ENSG00000104325; -.
DR   PharmGKB; PA141; -.
DR   eggNOG; KOG0725; Eukaryota.
DR   eggNOG; COG1028; LUCA.
DR   GeneTree; ENSGT00760000118868; -.
DR   HOVERGEN; HBG005465; -.
DR   InParanoid; Q16698; -.
DR   KO; K13236; -.
DR   OMA; FQSKFFP; -.
DR   OrthoDB; EOG091G0GO6; -.
DR   PhylomeDB; Q16698; -.
DR   TreeFam; TF315256; -.
DR   Reactome; R-HSA-77288; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids.
DR   SABIO-RK; Q16698; -.
DR   ChiTaRS; DECR1; human.
DR   EvolutionaryTrace; Q16698; -.
DR   GenomeRNAi; 1666; -.
DR   PRO; PR:Q16698; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104325; -.
DR   CleanEx; HS_DECR1; -.
DR   ExpressionAtlas; Q16698; baseline and differential.
DR   Genevisible; Q16698; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0070402; F:NADPH binding; IDA:UniProtKB.
DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; TAS:Reactome.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR002347; SDR_fam.
DR   PRINTS; PR00081; GDHRDH.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Fatty acid metabolism; Lipid metabolism; Mitochondrion; NADP;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     34       Mitochondrion. {ECO:0000250}.
FT   CHAIN        35    335       2,4-dienoyl-CoA reductase, mitochondrial.
FT                                /FTId=PRO_0000031965.
FT   NP_BIND      66     71       NADP. {ECO:0000269|PubMed:15531764}.
FT   NP_BIND     240    243       NADP. {ECO:0000269|PubMed:15531764}.
FT   ACT_SITE    199    199       Proton acceptor. {ECO:0000255}.
FT   BINDING      91     91       NADP. {ECO:0000269|PubMed:15531764}.
FT   BINDING      91     91       Substrate. {ECO:0000250}.
FT   BINDING     117    117       NADP. {ECO:0000269|PubMed:15531764}.
FT   BINDING     119    119       Substrate. {ECO:0000269|PubMed:15531764}.
FT   BINDING     149    149       Substrate. {ECO:0000269|PubMed:15531764}.
FT   BINDING     157    157       Substrate. {ECO:0000269|PubMed:15531764}.
FT   BINDING     214    214       NADP. {ECO:0000269|PubMed:15531764}.
FT   BINDING     251    251       Substrate. {ECO:0000250}.
FT   MOD_RES      42     42       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES      42     42       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES      49     49       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES      49     49       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES      69     69       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      73     73       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES      97     97       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES      97     97       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES     230    230       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     244    244       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES     244    244       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES     260    260       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES     260    260       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES     319    319       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   MOD_RES     319    319       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9CQ62}.
FT   VAR_SEQ       1     23       MKLPARVFFTLGSRLPCGLAPRR -> MSGLGKKHLLLMGE
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056388.
FT   VARIANT     333    333       K -> N (in dbSNP:rs15094).
FT                                /FTId=VAR_012034.
FT   MUTAGEN     148    148       N->A: Reduces enzyme activity by 97%.
FT                                {ECO:0000269|PubMed:15531764}.
FT   MUTAGEN     199    199       Y->A: Reduces enzyme activity by 99%.
FT                                Strongly reduced affinity for substrate
FT                                and for NADP.
FT                                {ECO:0000269|PubMed:15531764}.
FT   MUTAGEN     210    210       S->A: Reduces enzyme activity by over
FT                                99%. {ECO:0000269|PubMed:15531764}.
FT   MUTAGEN     214    214       K->A: Reduces enzyme activity by over
FT                                99%. {ECO:0000269|PubMed:15531764}.
FT   CONFLICT    287    287       D -> G (in Ref. 2; AAB09423).
FT                                {ECO:0000305}.
FT   CONFLICT    292    292       I -> V (in Ref. 2; AAB09423).
FT                                {ECO:0000305}.
FT   CONFLICT    303    303       E -> G (in Ref. 2; AAB09423).
FT                                {ECO:0000305}.
FT   CONFLICT    311    311       F -> G (in Ref. 2; AAB09423).
FT                                {ECO:0000305}.
FT   HELIX        36     43       {ECO:0000244|PDB:1W6U}.
FT   TURN         54     59       {ECO:0000244|PDB:1W6U}.
FT   STRAND       61     65       {ECO:0000244|PDB:1W6U}.
FT   TURN         66     68       {ECO:0000244|PDB:1W6U}.
FT   HELIX        70     81       {ECO:0000244|PDB:1W6U}.
FT   STRAND       85     91       {ECO:0000244|PDB:1W6U}.
FT   HELIX        93    107       {ECO:0000244|PDB:1W6U}.
FT   STRAND      111    115       {ECO:0000244|PDB:1W6U}.
FT   HELIX       121    134       {ECO:0000244|PDB:1W6U}.
FT   STRAND      139    143       {ECO:0000244|PDB:1W6U}.
FT   HELIX       153    155       {ECO:0000244|PDB:1W6U}.
FT   HELIX       158    185       {ECO:0000244|PDB:1W6U}.
FT   STRAND      190    195       {ECO:0000244|PDB:1W6U}.
FT   HELIX       199    202       {ECO:0000244|PDB:1W6U}.
FT   HELIX       208    228       {ECO:0000244|PDB:1W6U}.
FT   HELIX       229    231       {ECO:0000244|PDB:1W6U}.
FT   STRAND      233    240       {ECO:0000244|PDB:1W6U}.
FT   STRAND      254    256       {ECO:0000244|PDB:1W73}.
FT   HELIX       257    263       {ECO:0000244|PDB:1W6U}.
FT   HELIX       274    284       {ECO:0000244|PDB:1W6U}.
FT   HELIX       287    289       {ECO:0000244|PDB:1W6U}.
FT   STRAND      296    300       {ECO:0000244|PDB:1W6U}.
FT   HELIX       303    308       {ECO:0000244|PDB:1W6U}.
FT   HELIX       312    316       {ECO:0000244|PDB:1W6U}.
FT   HELIX       319    325       {ECO:0000244|PDB:1W6U}.
SQ   SEQUENCE   335 AA;  36068 MW;  F04E72AACB718430 CRC64;
     MKLPARVFFT LGSRLPCGLA PRRFFSYGTK ILYQNTEALQ SKFFSPLQKA MLPPNSFQGK
     VAFITGGGTG LGKGMTTLLS SLGAQCVIAS RKMDVLKATA EQISSQTGNK VHAIQCDVRD
     PDMVQNTVSE LIKVAGHPNI VINNAAGNFI SPTERLSPNA WKTITDIVLN GTAFVTLEIG
     KQLIKAQKGA AFLSITTIYA ETGSGFVVPS ASAKAGVEAM SKSLAAEWGK YGMRFNVIQP
     GPIKTKGAFS RLDPTGTFEK EMIGRIPCGR LGTVEELANL AAFLCSDYAS WINGAVIKFD
     GGEEVLISGE FNDLRKVTKE QWDTIEELIR KTKGS
//
